362 related articles for article (PubMed ID: 9754647)
1. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
Bontkes HJ; van Duin M; de Gruijl TD; Duggan-Keen MF; Walboomers JM; Stukart MJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ; Stevens FR; Dyer PA; Sinnott P; Stern PL
Int J Cancer; 1998 Oct; 78(2):166-71. PubMed ID: 9754647
[TBL] [Abstract][Full Text] [Related]
2. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis.
van Duin M; Snijders PJ; Vossen MT; Klaassen E; Voorhorst F; Verheijen RH; Helmerhorst TJ; Meijer CJ; Walboomers JM
J Gen Virol; 2000 Feb; 81(Pt 2):317-25. PubMed ID: 10644829
[TBL] [Abstract][Full Text] [Related]
3. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer.
Nindl I; Rindfleisch K; Lotz B; Schneider A; Dürst M
Int J Cancer; 1999 Jul; 82(2):203-7. PubMed ID: 10389753
[TBL] [Abstract][Full Text] [Related]
4. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer.
Matsumoto K; Yasugi T; Nakagawa S; Okubo M; Hirata R; Maeda H; Yoshikawa H; Taketani Y
Int J Cancer; 2003 Oct; 106(6):919-22. PubMed ID: 12918070
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters.
Brady CS; Duggan-Keen MF; Davidson JA; Varley JM; Stern PL
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3233-3240. PubMed ID: 10567656
[TBL] [Abstract][Full Text] [Related]
8. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
[TBL] [Abstract][Full Text] [Related]
9. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
[TBL] [Abstract][Full Text] [Related]
10. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia.
Kadish AS; Ho GY; Burk RD; Wang Y; Romney SL; Ledwidge R; Angeletti RH
J Natl Cancer Inst; 1997 Sep; 89(17):1285-93. PubMed ID: 9293919
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.
Kaufmann AM; Stern PL; Rankin EM; Sommer H; Nuessler V; Schneider A; Adams M; Onon TS; Bauknecht T; Wagner U; Kroon K; Hickling J; Boswell CM; Stacey SN; Kitchener HC; Gillard J; Wanders J; Roberts JS; Zwierzina H
Clin Cancer Res; 2002 Dec; 8(12):3676-85. PubMed ID: 12473576
[TBL] [Abstract][Full Text] [Related]
12. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer.
Tornesello ML; Duraturo ML; Salatiello I; Buonaguro L; Losito S; Botti G; Stellato G; Greggi S; Piccoli R; Pilotti S; Stefanon B; De Palo G; Franceschi S; Buonaguro FM
J Med Virol; 2004 Sep; 74(1):117-26. PubMed ID: 15258977
[TBL] [Abstract][Full Text] [Related]
13. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.
Zehbe I; Mytilineos J; Wikström I; Henriksen R; Edler L; Tommasino M
Hum Immunol; 2003 May; 64(5):538-42. PubMed ID: 12691704
[TBL] [Abstract][Full Text] [Related]
14. T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection.
de Gruijl TD; Bontkes HJ; Stukart MJ; Walboomers JM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2183-91. PubMed ID: 8811018
[TBL] [Abstract][Full Text] [Related]
15. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development.
Zehbe I; Voglino G; Wilander E; Delius H; Marongiu A; Edler L; Klimek F; Andersson S; Tommasino M
Cancer Res; 2001 Jan; 61(2):608-11. PubMed ID: 11212257
[TBL] [Abstract][Full Text] [Related]
16. Distribution of human papillomavirus type 16 E6 and E7 gene variants in the progression of cervical dysplasia in Korean women.
Lee CW; Bae JH; Lee SJ; Ho EM; Lee IH; Park YG; Park JS
J Obstet Gynaecol Res; 2011 Oct; 37(10):1320-6. PubMed ID: 21535311
[TBL] [Abstract][Full Text] [Related]
17. Distribution of human papillomavirus 16 E6/E7 variants in cervical cancer and intraepithelial neoplasia in Chinese women.
Ding T; Wang X; Ye F; Cheng X; Lu W; Xie X
Int J Gynecol Cancer; 2010 Nov; 20(8):1391-8. PubMed ID: 21051983
[TBL] [Abstract][Full Text] [Related]
18. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
[TBL] [Abstract][Full Text] [Related]
19. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
20. Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses.
Mizuuchi M; Hirohashi Y; Torigoe T; Kuroda T; Yasuda K; Shimizu Y; Saito T; Sato N
Exp Mol Pathol; 2012 Feb; 92(1):185-90. PubMed ID: 22032938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
